Table 3 Timing of AF occurrence, pharmacological conversion agents use, and timing from antiarrhythmic drug administration to pharmacological cardioversion and BP and HR at the time of baseline, before and after AF occurrence
Non-pharmacological intervention (n = 388) | Pharmacological conversion (n = 258) | p-value | |
|---|---|---|---|
Timing of AF occurrence after operation beginning [median (IQR), min] | 75 (50) | 85 (45) | 0.139 |
Different periods of AF occurrence during operations | 0.095 | ||
Entering thoracic cavity (n, %) | 10 (2.6) | 4 (1.6) | |
Targeted lung or esophagus resection (n, %) | 91 (23.5) | 83 (32.2) | |
Lymph node dissection (n, %) | 232 (59.8) | 141 (54.7) | |
Chest closure (n, %) | 55 (14.2) | 31 (12.0) | |
Timing of receiving pharmacological conversion agents [median (IQR), min] | - | 5 (3) | - |
Timing from antiarrhythmic drug administration to pharmacological cardioversion [median (IQR), min] | - | 66 (67.5) | - |
SBP | |||
Before anesthesia (mmHg) | 136.67 ± 21.23 | 134.48 ± 25.71 | 0.238 |
5–10 min before AF (mmHg) | 117.81 ± 16.97 | 120.31 ± 17.38 | 0.185 |
3–5 min after AF (mmHg) | 117.37 ± 16.67 | 114.89 ± 20.31 | 0.232 |
BDP | |||
Before anesthesia (mmHg) | 76.76 ± 11.56 | 75.89 ± 13.47 | 0.381 |
5–10 min before AF (mmHg) | 64.00 ± 9.51 | 65.53 ± 9.97 | 0.152 |
3–5 min after AF (mmHg) | 65.86 ± 10.83 | 63.96 ± 11.84 | 0.127 |
HR | |||
Before anesthesia (beats/min) | 75.78 ± 10.51 | 75.59 ± 11.66 | 0.829 |
5–10 min before AF (beats/min) | 76.55 ± 16.20 | 74.79 ± 11.97 | 0.247 |
3–5 min after AF (beats/min) | 82.76 ± 20.26 | 86.43 ± 23.64 | 0.131 |